Literature DB >> 12935929

Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases.

M Jarosová1, M Holzerová, V Mihál, I Lakomá, V Divoký, B Blazek, D Pospísilová, M Hajdúch, Z Novák, L Dusek, J Koptíková, T S Poulsen, K Indrák.   

Abstract

Cytogenetic and molecular cytogenetic analysis of 79 childhood acute lymphoblastic leukemias (ALL) revealed chromosomal abnormalities in 76 (96%). Complex karyotypes (a finding of three and more chromosomal aberrations in a karyotype) were identified in 21 (26.6%) out of 79 patients. In 11 patients, complex karyotypes have included common recurrent chromosomal abnormalities, such as translocation t(12;21) in seven cases, t(9;22) in two cases, one case with t(2;1;19) and another one with translocation involving 11q23. In 10 patients, miscellaneous abnormalities were detected. Five patients displayed hyperdiploidy (47 approximately 57 chromosomes), three patients complex karyotypes with deletions of 9p, one patient with two new complex translocations t(2;4;12;13) and t(7;11;20), and the last patient with dic(12;21). The evaluation of the frequency of the chromosomal breaks (>5 per chromosome) showed that chromosomes 2, 4, 5, 7, 9, 12, 13, and 21 were most frequently affected. Survival analysis revealed statistically significant unfavorable event-free survival (EFS) (P=0.013) and decreased overall survival in the group with complex karyotypes (n=21) compared with the other cases (n=58). The evaluation of overexpression profile revealed increased occurrence of double CD13/CD33 positivity in patients with common recurrent chromosomal abnormalities (in 70% of cases); no such cases were registered in the other group (P<0.01).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12935929     DOI: 10.1016/s0165-4608(03)00099-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease.

Authors:  Ghayas C Issa; Hagop M Kantarjian; C Cameron Yin; Wei Qiao; Farhad Ravandi; Deborah Thomas; Nicholas J Short; Koji Sasaki; Guillermo Garcia-Manero; Tapan M Kadia; Jorge E Cortes; Naval Daver; Gautam Borthakur; Nitin Jain; Marina Konopleva; Issa Khouri; Partow Kebriaei; Richard E Champlin; Sherry Pierce; Susan M O'Brien; Elias Jabbour
Journal:  Cancer       Date:  2016-10-03       Impact factor: 6.860

2.  Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions.

Authors:  Yiping Zhu; Rong Yang; Ju Gao; Yanle Zhang; Ge Zhang; Ling Gu
Journal:  Cancer Cell Int       Date:  2019-04-29       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.